JP2018016588A - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- JP2018016588A JP2018016588A JP2016148618A JP2016148618A JP2018016588A JP 2018016588 A JP2018016588 A JP 2018016588A JP 2016148618 A JP2016148618 A JP 2016148618A JP 2016148618 A JP2016148618 A JP 2016148618A JP 2018016588 A JP2018016588 A JP 2018016588A
- Authority
- JP
- Japan
- Prior art keywords
- arginine
- containing composition
- proanthocyanidin
- composition
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 96
- 239000004475 Arginine Substances 0.000 claims abstract description 38
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 38
- 230000006872 improvement Effects 0.000 claims abstract description 29
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 claims abstract description 28
- 229920001991 Proanthocyanidin Polymers 0.000 claims abstract description 28
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 14
- 239000008187 granular material Substances 0.000 claims abstract description 12
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims abstract description 11
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims abstract description 11
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229960002173 citrulline Drugs 0.000 claims abstract description 11
- 235000013477 citrulline Nutrition 0.000 claims abstract description 11
- 239000011701 zinc Substances 0.000 claims abstract description 11
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 11
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 8
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 8
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims abstract description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019152 folic acid Nutrition 0.000 claims abstract description 7
- 239000011724 folic acid Substances 0.000 claims abstract description 7
- 229960000304 folic acid Drugs 0.000 claims abstract description 7
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 6
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 6
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 6
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 6
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 5
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 5
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 5
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 5
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 5
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 4
- 229960003624 creatine Drugs 0.000 claims abstract description 4
- 239000006046 creatine Substances 0.000 claims abstract description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 4
- 239000011709 vitamin E Substances 0.000 claims abstract description 4
- 229940046009 vitamin E Drugs 0.000 claims abstract description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 3
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 3
- 239000011718 vitamin C Substances 0.000 claims abstract description 3
- 230000036299 sexual function Effects 0.000 claims description 22
- 229920002770 condensed tannin Polymers 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 49
- 239000007902 hard capsule Substances 0.000 abstract description 8
- 240000005739 Eurycoma longifolia Species 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000037406 food intake Effects 0.000 description 8
- 229960003604 testosterone Drugs 0.000 description 8
- 208000010228 Erectile Dysfunction Diseases 0.000 description 7
- 201000001881 impotence Diseases 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 206010036618 Premenstrual syndrome Diseases 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000000509 infertility Diseases 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- 231100000535 infertility Toxicity 0.000 description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 229930003270 Vitamin B Natural products 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 235000018192 pine bark supplement Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229940106796 pycnogenol Drugs 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000009233 Morning Sickness Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000005105 Pinus pinaster Nutrition 0.000 description 1
- 241001236212 Pinus pinaster Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 208000034850 Vomiting in pregnancy Diseases 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 235000020741 pine bark extract Nutrition 0.000 description 1
- 229940106587 pine bark extract Drugs 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本発明は、経口組成物、特に、男性の性的機能改善用経口組成物に関する。 The present invention relates to an oral composition, in particular, an oral composition for improving male sexual function.
従来、アルギニンとプロアントシアニジンを組み合わせて摂取することで、勃起不全(ED)、不妊、精力減退等の男性の性的機能の改善に効果があることが知られ、これらを含有するサプリメント等の経口組成物の開発がなされている(例えば、特許文献1参照)。男性の性的機能の低下は、血流低下によって引き起こされることが多い。そのため、特許文献1では、血管の拡張効果を有するアルギニンとプロアントシアニジンを摂取させることで血流の改善を促し、性的機能の改善を図っている。また、特許文献2には、シトルリン及びアルギニンを含有する経口剤を摂取することで、血流が改善され、勃起不全の症状に対して効果があることが開示されている。 Conventionally, taking arginine and proanthocyanidins in combination has been known to be effective in improving sexual functions in men, such as erectile dysfunction (ED), infertility, and reduced energy, and oral supplements containing these Compositions have been developed (see, for example, Patent Document 1). The decline in male sexual function is often caused by decreased blood flow. Therefore, in patent document 1, the improvement of a blood flow is promoted by ingesting the arginine and proanthocyanidin which have the vasodilator effect, and the improvement of a sexual function is aimed at. Patent Document 2 discloses that ingestion of an oral preparation containing citrulline and arginine improves blood flow and is effective against symptoms of erectile dysfunction.
しかしながら、特許文献1の経口組成物では、性的機能の改善効果が現れるまでに、数カ月以上摂取する必要があり、即効性等に問題があった。特許文献2の経口組成物では、性的機能が十分に解消されたか否か具体的には記載されていない。そのたため、性的機能の改善効果に優れ、かつその効果がより速く得られる経口組成物の開発が望まれている。 However, the oral composition of Patent Document 1 requires ingestion for several months or more before the effect of improving sexual function appears, and there is a problem in immediate effect and the like. In the oral composition of patent document 2, it is not specifically described whether the sexual function was fully eliminated. Therefore, it is desired to develop an oral composition that is excellent in improving the sexual function and can be obtained more quickly.
本発明は、上記問題に着目してなされたもので、性的機能等の優れた改善効果を、より速く、より効果的に発揮することが可能な経口組成物を提供することを目的とする。 The present invention has been made paying attention to the above problems, and an object thereof is to provide an oral composition capable of exhibiting an excellent improvement effect such as sexual function faster and more effectively. .
上記目的を達成するため、本発明の経口剤は、アルギニン、アスパラギン酸ナトリウム、及びシトルリンを含有するアルギニン含有組成物と、プロアントシアニジン、及び亜鉛を含有するプロアントシアニジン含有組成物と、を有するものである。 In order to achieve the above object, an oral preparation of the present invention comprises an arginine-containing composition containing arginine, sodium aspartate, and citrulline, and a proanthocyanidin-containing composition containing proanthocyanidins and zinc. is there.
本発明によれば、性的機能等の優れた改善効果を、より速く、より効果的に発揮することが可能な経口組成物を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the oral composition which can exhibit the outstanding improvement effect, such as a sexual function, faster and more effectively can be provided.
以下、本発明の経口組成物の一実施形態を説明する。本実施形態に係る経口組成物は、アルギニン、アスパラギン酸ナトリウム、及びシトルリンを含有するアルギニン含有組成物と、プロアントシアニジン、及び亜鉛を含有するプロアントシアニジン含有組成物と、有している。本実施形態に係る経口組成物は、ヒト又はヒト以外の動物への経口摂取や経口投与が行われるものであり、サプリメントとして、健康食品、機能性食品、栄養補助食品、特定保健用食品等の飲食品として、又は医薬品等として提供することができる。 Hereinafter, an embodiment of the oral composition of the present invention will be described. The oral composition according to this embodiment has an arginine-containing composition containing arginine, sodium aspartate, and citrulline, and a proanthocyanidin-containing composition containing proanthocyanidins and zinc. The oral composition according to the present embodiment is for oral ingestion and oral administration to humans or non-human animals, and supplements such as health foods, functional foods, dietary supplements, foods for specified health use, etc. It can be provided as a food or drink or as a medicine.
アルギニン、アスパラギン酸ナトリウム、及びシトルリンとしては、L−体、D−体及びDL−体の何れであってもよいが、L−体が望ましい。 Arginine, sodium aspartate, and citrulline may be any of L-form, D-form and DL-form, but L-form is desirable.
また、アルギニン含有組成物は、アルギニン、アスパラギン酸ナトリウム、及びシトルリンに加えて、ビタミンC、ビタミンE、及び葉酸から選択される少なくとも1つをさらに含有することが望ましく、2以上の成分をさらに含有することがより望ましく、これらすべての成分を含有することが特に望ましい。また、これらの以外の成分を含有させることもできる。 The arginine-containing composition preferably further contains at least one selected from vitamin C, vitamin E, and folic acid in addition to arginine, sodium aspartate, and citrulline, and further contains two or more components. It is more desirable to contain all these components. Moreover, components other than these can also be contained.
また、プロアントシアニジン含有組成物は、プロアントシアニジン、及び亜鉛に加えて、クレアチン、トンカットアリ抽出物、コエンザイムQ10、ビタミンB6、及びビタミンB12から選択される少なくとも1つをさらに含有することが望ましく、2以上の成分をさらに含有することがより望ましく、これらの成分すべてを含有することが特に望ましい。この場合も、これら以外の成分を含有させることもできる。 The proanthocyanidin-containing composition preferably further contains at least one selected from creatine, tonkat ant extract, coenzyme Q10, vitamin B6, and vitamin B12 in addition to proanthocyanidins and zinc, It is more desirable to further include two or more components, and it is particularly desirable to include all of these components. In this case, components other than these can also be contained.
以下、アルギニン含有組成物の各成分について説明する。アルギニンは、アミノ酸の一種であり、成長ホルモンの分泌を促進することから、血管の拡張による血流改善効果を有している。アルギニンは、血流改善効果の他にも、筋肉合成、免疫力の向上、アンモニアの解毒等の効果を有している。 Hereinafter, each component of the arginine-containing composition will be described. Arginine is a kind of amino acid and promotes the secretion of growth hormone, and thus has an effect of improving blood flow by dilating blood vessels. Arginine has effects such as muscle synthesis, improvement of immunity, detoxification of ammonia, etc. in addition to the blood flow improvement effect.
アスパラギン酸は、アミノ酸の一種であり、利尿作用によってアンモニアを体外へ排出する効果、窒素代謝やエネルギー代謝に関与して疲労を回復する効果を有している。なお、アスパラギン酸は水に溶けにくいため、ナトリウムと化合させたアスパラギン酸ナトリウムを用いることが、水溶性を向上させる観点から望ましい。 Aspartic acid is a kind of amino acid, and has an effect of excreting ammonia out of the body by diuretic action, and an effect of recovering fatigue by being involved in nitrogen metabolism and energy metabolism. Since aspartic acid is hardly soluble in water, it is desirable to use sodium aspartate combined with sodium from the viewpoint of improving water solubility.
シトルリンは、アミノ酸の一種であり、キュウリやスイカ等の野菜に多く含まれている。シトルリンは、一酸化窒素の生産を促すことで、血管を拡張させる効果を有している。そのため、血流改善効果、疲労回復効果、筋肉増強効果、精力増強効果が得られる。 Citrulline is a kind of amino acid and is abundant in vegetables such as cucumber and watermelon. Citrulline has the effect of dilating blood vessels by promoting the production of nitric oxide. Therefore, a blood flow improvement effect, a fatigue recovery effect, a muscle enhancement effect, and an energy enhancement effect can be obtained.
ビタミンC(アスコルビン酸)は、水溶性ビタミンの一種であり、皮膚や粘膜の健康維持を助けるとともに、抗酸化作用を有している。そのため、免疫力やストレスに対する抵抗力を向上させる効果を有している。 Vitamin C (ascorbic acid) is a kind of water-soluble vitamin, which helps maintain the health of the skin and mucous membranes and has an antioxidant effect. Therefore, it has the effect of improving immunity and resistance to stress.
ビタミンEは、強い抗酸化作用を持つビタミンの一種であり、活性酸素から体を守る効果を有している。また、血管や肌・細胞などの老化を防止して生殖機能を維持する効果や、末梢血管を拡張させて血行を促進する効果を有している。 Vitamin E is a kind of vitamin having a strong antioxidant action, and has an effect of protecting the body from active oxygen. It also has the effect of preventing aging of blood vessels, skin, cells, etc. and maintaining reproductive function, and the effect of promoting peripheral blood vessels to promote blood circulation.
葉酸は、水溶性のビタミンB群の一種であり、ビタミンB12とともに赤血球の形成を助ける効果を有する。また、葉酸は、葉酸は胎児の正常な発育に寄与する栄養素としても重要な働きを行うため、主に妊娠初期の女性が好んで摂取している。他方、男性が葉酸を摂取することで、精子の正常な分裂を促進し、妊娠の確率を向上させる効果や奇形のリスクを下げる効果があることが知られており、勃起不全や不妊等、男性の性的機能の改善に優れた効果を発揮することができる。 Folic acid is a kind of water-soluble vitamin B group, and has an effect of helping the formation of red blood cells together with vitamin B12. In addition, folic acid is mainly consumed by women in early pregnancy because folic acid plays an important role as a nutrient that contributes to the normal development of the fetus. On the other hand, it is known that when men ingest folic acid, it promotes normal sperm division, improves the probability of pregnancy, and lowers the risk of malformation. It is possible to exert an excellent effect on improving the sexual function.
次に、プロアントシアニジン含有組成物の各成分について説明する。プロアントシアニジンは、フラボノイドの一種であり、強い抗酸化作用を有するとともに、血管壁内にある一酸化窒素合成酵素を活性化して血管拡張を引き起こす作用を有している。そのため、血流を改善する効果が得られる。 Next, each component of the proanthocyanidin-containing composition will be described. Proanthocyanidins are a kind of flavonoid, have a strong antioxidant action, and also have an action of activating nitrous oxide synthase in the blood vessel wall to cause vasodilation. Therefore, the effect of improving blood flow can be obtained.
プロアントシアニジンは、ブドウ、樹皮、茶、カカオ等の多くの植物に含有されている。この中でも、プロアントシアニジンを多く含有することから、ピクノジェノール(登録商標、学名:Pinus Pinaster ssp.natlantica)が好適に用いられる。ピクノジェノールは、フランス南西部の海岸地帯に自生する松の樹皮から抽出された成分であり、フランス海岸松樹皮エキス,フラバンジェノール等とも呼ばれている。 Proanthocyanidins are contained in many plants such as grapes, bark, tea and cacao. Among these, Pycnogenol (registered trademark, Pinus Pinaster ssp. Natlantica) is preferably used because it contains a large amount of proanthocyanidins. Pycnogenol is a component extracted from the bark of pine that grows naturally in the coastal area in southwestern France, and is also called French coastal pine bark extract, flavangenol, and the like.
ピクノジェノールの効果として、ED等の男性の性的機能の改善効果が挙げられ、この他にも高血圧や糖尿病などの予防や改善、免疫機能強化、アレルギーの改善、月経困難症,子宮内膜症、血栓予防、美肌・美白効果、鎮痛作用、ADHD(注意欠陥・多動性障害)の改善、静脈不全、静脈瘤の改善効果等が挙げられる。 The effects of Pycnogenol include the improvement of sexual function in men such as ED. In addition to this, prevention and improvement of hypertension and diabetes, immune function enhancement, allergy improvement, dysmenorrhea, endometriosis, Examples include thrombus prevention, skin beautification / whitening effect, analgesic effect, improvement of ADHD (attention deficit / hyperactivity disorder), venous insufficiency, varicose vein improvement and the like.
亜鉛は、牡蠣や肉類、魚など動物性食品に多く含まれるミネラルであり、たんぱく質・核酸の代謝に関与して、健康を維持する効果や味覚を正常に保つ効果を有する。特に、亜鉛は、男性の体内で精子が生産される過程において必要不可欠な栄養素であり、亜鉛を摂取することは、EDや不妊等の男性の性的機能の改善に効果的である。亜鉛の種類としては、特に限定されないが、保険機能食品への添加が認められていることから、グルコン酸亜鉛が好適に用いられる。 Zinc is a mineral that is abundant in animal foods such as oysters, meats, and fish, and is involved in protein / nucleic acid metabolism and has the effect of maintaining health and the effect of maintaining a normal taste. In particular, zinc is an essential nutrient in the process of producing sperm in a male body, and taking zinc is effective in improving male sexual functions such as ED and infertility. Although it does not specifically limit as a kind of zinc, Since addition to an insurance functional food is recognized, zinc gluconate is used suitably.
クレアチンは、エネルギー源として筋肉中に貯蔵されるアミノ酸の一種であり、筋力や身体機能、持久力の向上効果を有し、スポーツ等に適しているとされている。そのため、男性機能の持続のために好適に用いることができる。トンカットアリ抽出物は、熱帯雨林に自生するトンカットリアと呼ばれる植物からの抽出物であり、古くから強壮剤として使用さている。特に男性の滋養強壮や男性ホルモンの分泌促進等に有効である。 Creatine is a kind of amino acid stored in muscle as an energy source, has an effect of improving muscular strength, physical function and endurance, and is considered suitable for sports and the like. Therefore, it can be suitably used for the maintenance of male function. Tonkat ant extract is an extract from a plant called Tonkat rear that grows naturally in the rainforest and has been used as a tonic since ancient times. In particular, it is effective for male nutrition and promotion of male hormone secretion.
コエンザイムQ10は、体内のエネルギーをつくるために必要となる補酵素の一種である。コエンザイムQ10は、ATPを産生して様々な生命活動の原動力を生み出すほか、強い抗酸化作用を持つことから、生活習慣病や老化の予防効果を有している。そのため、男性の精子の質を向上させる効果や、精子の運動能力を改善する効果が得られる。 Coenzyme Q10 is a type of coenzyme that is necessary for producing energy in the body. Coenzyme Q10 produces ATP and produces a driving force for various life activities, and has a strong antioxidant effect, and thus has a preventive effect on lifestyle-related diseases and aging. Therefore, the effect which improves the quality of a male sperm and the effect which improves the exercise | movement ability of a sperm are acquired.
ビタミンB6は、水溶性のビタミンB群の一種で、アミノ酸の代謝や神経伝達物質の合成に寄与する。そのため、精神状態を安定させ、ホルモンのバランスを整える作用があり、男性の性的機能の改善効果が得られるとともに、女性のPMS(月経前症候群)の症状やつわりを緩和する効果も得られる。ビタミンB6としては、特に限定されないが、ピリドキシン塩酸塩が好適に用いられる。 Vitamin B6 is a kind of water-soluble vitamin B group, and contributes to amino acid metabolism and neurotransmitter synthesis. Therefore, it has the effect of stabilizing the mental state and adjusting the balance of hormones, improving the sexual function of males, and reducing the symptoms and morning sickness of female PMS (premenstrual syndrome). Vitamin B6 is not particularly limited, but pyridoxine hydrochloride is preferably used.
ビタミンB12(シアノコバラミン)は、水溶性のビタミンB群の一種で、細胞の代謝に関与しており、特にDNAや蛋白質の合成と調整、脂肪酸の合成とエネルギー産生に関与する等、体内での様々な代謝に関与している。このことから、ビタミンB12は、精子の生成機能を向上させる効果や、精子の運動能力を向上させる効果が得られる。 Vitamin B12 (cyanocobalamin) is a kind of water-soluble vitamin B group, and is involved in cell metabolism, especially in the synthesis and regulation of DNA and proteins, and in the synthesis of fatty acids and energy production. Is involved in proper metabolism. From this, vitamin B12 has the effect of improving the sperm production function and the effect of improving the sperm motility.
以上、本実施形態の経口組成物によれば、血流改善効果や疲労回復効果等に優れるアルギニン含有組成物と、精子の生成機能の向上や精子の運動能力の向上効果、血流改善効果等に優れるプロアントシアニジン含有組成物とを有することで、性的機能の改善効果、特に、勃起不全、不妊等の男性の性的機能の優れた改善効果を得ることができる。すなわち、本実施形態の経口組成物の摂取により、テストステロン等の男性ホルモンの分泌の促進、ホルモンバランスの調整、精子の生成促進や精子の質の向上等が図られ、性的機能が改善される。この他にも肩こり、冷え症、むくみ等の改善効果や、女性の月経前症候群(PMS)、女性の不妊等の改善効果も得ることができる。 As described above, according to the oral composition of the present embodiment, an arginine-containing composition excellent in blood flow improvement effect, fatigue recovery effect, etc., an improvement in sperm production function, an improvement in sperm exercise ability, a blood flow improvement effect, etc. By having an excellent proanthocyanidin-containing composition, it is possible to obtain an effect of improving sexual function, particularly an effect of improving male sexual function such as erectile dysfunction and infertility. That is, by ingesting the oral composition of the present embodiment, promotion of secretion of male hormones such as testosterone, adjustment of hormone balance, promotion of sperm production and improvement of sperm quality, etc. are achieved, and sexual function is improved. . In addition to this, it is possible to obtain improvement effects such as stiff shoulders, coldness and swelling, and improvement effects such as premenstrual syndrome (PMS) in women and infertility in women.
また、アルギニン含有組成物が、アスパラギン酸ナトリウム及びシトルリンを含有することで、アルギニンの作用効果をより向上させるとともに、その効果をより速やかに発現させることができる。また、プロアントシアニジン含有組成物が、亜鉛を含有することで、プロアントシアニジンの作用効果をより向上させるとともに、その効果をより速やかに発現させることができる。したがって、男性の性的機能等の優れた改善効果を、より速く、より効果的に発揮することが可能な経口組成物を提供することができる。 Moreover, while an arginine containing composition contains sodium aspartate and citrulline, while improving the effect of arginine more, the effect can be expressed more rapidly. Moreover, while the proanthocyanidin-containing composition contains zinc, the effects of proanthocyanidins can be further improved and the effects can be expressed more quickly. Therefore, it is possible to provide an oral composition capable of exhibiting superior improvement effects such as male sexual function faster and more effectively.
本実施形態の経口組成物は、アルギニン含有組成物とプロアントシアニジン含有組成物とをそのまま摂取又は投与することもできるが、公知の製剤として提供して摂取又は投与させることが望ましい。 Although the arginine-containing composition and the proanthocyanidin-containing composition can be ingested or administered as they are, the oral composition of this embodiment is desirably provided as a known preparation and ingested or administered.
本実施形態の経口組成物の剤形としては、例えば錠剤、散剤、顆粒剤、乳剤、シロップ剤、カプセル剤(ハードカプセル剤、ソフトカプセル剤)等が挙げられる。アルギニン含有組成物とプロアントシアニジン含有組成物とは、同一の剤形とすることもできるし、異なる剤形とすることもできる。例えば、アルギニン含有組成物が顆粒剤又は散剤であり、プロアントシアニジン含有組成物がカプセル剤であることが望ましい。アルギニン含有組成物は、アルギニンを含むため、摂取量が多くなり、錠剤等よりも顆粒剤や散剤とする方が摂取又は投与し易いため望ましい。プロアントシアニジン含有組成物は、摂取量が少なくても優れた効果が得られるため、錠剤としたりカプセルに充填することで摂取又は投与がし易くなるとともに、分包等の必要がなく、製造コストを低減できるため望ましい。 Examples of the dosage form of the oral composition of the present embodiment include tablets, powders, granules, emulsions, syrups, capsules (hard capsules, soft capsules) and the like. The arginine-containing composition and the proanthocyanidin-containing composition can be the same dosage form or different dosage forms. For example, it is desirable that the arginine-containing composition is a granule or powder, and the proanthocyanidin-containing composition is a capsule. Since an arginine-containing composition contains arginine, the amount of intake is increased, and it is desirable to use a granule or powder rather than a tablet or the like because it is easier to ingest or administer. Proanthocyanidin-containing compositions can provide excellent effects even when the amount of intake is small, so it is easy to ingest or administer by filling into tablets or capsules, and there is no need for packaging, etc. This is desirable because it can be reduced.
また、本発明の経口組成物を製剤化する際には、例えば賦形剤、甘味料等の添加剤を用いることができる。賦形剤としては、例えば、デンプン、セルロース、ショ糖や乳頭等の糖類等が挙げられ、この中でもデンプンが好適に用いられる。甘味料としては、アスパルテーム、アセスルファムカリウム、サッカリンナトリウム、スクラロース、ステビア、ソーマチン等が挙げられる。これらの添加剤は、例示したものの中から1種を選択して用いることもできるし、複数種を適宜組み合わせて用いることもできる。 Moreover, when formulating the oral composition of this invention, additives, such as an excipient | filler and a sweetener, can be used, for example. Examples of the excipient include starch, cellulose, saccharides such as sucrose and teat, and among these, starch is preferably used. Examples of the sweetener include aspartame, acesulfame potassium, saccharin sodium, sucralose, stevia, thaumatin and the like. These additives can be used by selecting one type from those exemplified, or a plurality of types can be used in appropriate combination.
また、この他にも、添加剤として結合剤、崩壊剤、滑沢剤、分散剤、懸濁剤、乳化剤、希釈剤、緩衝剤、抗酸化剤、細菌抑制剤、矯味剤、着香剤(香料)、着色剤等を用いることもできる。製剤化の製造方法や製造装置としては、特に限定されることはなく、従来公知の適宜の製造方法や製造装置を剤形等に応じて選択することができる。 In addition, binders, disintegrants, lubricants, dispersants, suspending agents, emulsifiers, diluents, buffers, antioxidants, bacteria inhibitors, flavoring agents, flavoring agents (additives) Perfume), coloring agents, and the like. There are no particular limitations on the production method and production apparatus for the formulation, and a conventionally known appropriate production method and production apparatus can be selected according to the dosage form and the like.
本実施形態の経口組成物は、アルギニン含有組成物と、プロアントシアニジン含有組成物とをすべて含有するように製剤することもできるが、錠剤等が大きくなることや、摂取又は投与量が多くなることがある。そのため、アルギニン含有組成物と、プロアントシアニジン含有組成物とをそれぞれ別々に製剤化し、それらを組み合わせて、キット又はセット物として提供することが望ましい。この場合、同一の箱、その他の容器に収容して提供することもできるし、別々の容器に収容して別々に提供することもできる。 The oral composition of the present embodiment can be formulated so as to contain all of the arginine-containing composition and the proanthocyanidin-containing composition, but the tablets and the like are increased, and the intake or dosage is increased. There is. Therefore, it is desirable to formulate the arginine-containing composition and the proanthocyanidin-containing composition separately, and combine them to provide a kit or a set. In this case, it can be provided in the same box or other container, or can be provided in a separate container.
このような形態での提供により、アルギニン含有組成物及びプロアントシアニジン含有組成物の一方をまず摂取等し、その後に他方を摂取等することができ、摂取等を行い易くなる。また、別々に提供することで、一方の摂取量等を多くし、他方の摂取量等を少なくするなど、症状や改善目的等に応じて、摂取量等を調整することができ、よりユーザの要求に対応した摂取等が可能となる。また、キット又はセット物として販売等してもよいが、別々に販売等することもでき、一方の組成物のみを摂取し終わって、他方の組成物が残っている場合、摂取し終わった組成物のみ買い足せばよく、ユーザが購買し易い製品となる。 By providing in such a form, one of the arginine-containing composition and the proanthocyanidin-containing composition can be ingested first, and then the other can be ingested. In addition, by providing separately, the intake etc. can be adjusted according to the symptom and the purpose of improvement, such as increasing the intake of one, etc., and reducing the intake of the other, etc. Ingestion according to the request becomes possible. In addition, it may be sold as a kit or a set, but can also be sold separately, etc., when only one composition has been consumed and the other composition remains, the composition that has been consumed It is sufficient to purchase only goods, and the product is easy for the user to purchase.
本実施形態の経口組成物は、プロアントシアニジン含有組成物1重量部に対して、アルギニン含有組成物を2重量部以上、好ましくは4重量部以上の割合で含有することが望ましい。また、成分比としては、アルギニン:アスパラギン酸ナトリウム:シトルリン:プロロアントシアニジン:亜鉛は、250:60:17:1:2.5とすることが望ましい。 The oral composition of the present embodiment desirably contains the arginine-containing composition at a ratio of 2 parts by weight or more, preferably 4 parts by weight or more with respect to 1 part by weight of the proanthocyanidin-containing composition. As a component ratio, arginine: sodium aspartate: citrulline: proloanthocyanidin: zinc is preferably 250: 60: 17: 1: 2.5.
本実施形態の経口組成物の摂取量及び摂取回数は、摂取形態、被摂取者の年齢、体重、症状等により異なる。通常、成人1日当り、アルギニン含有組成物として、5,000〜7,000mg、プロアントシアニジン含有組成物として、1,500〜2,000mgを摂取することが望ましい。この分量を1日1回から数回摂取することが望ましく、1日2回に分けて摂取することが最も望ましい。本実施形態の経口組成物は、性的機能の改善効果をより速く発現させることができるため、摂取期間としては、従来よりも短くてよいが、例えば2週間以上が望ましい。また、優れた改善効果をより持続させるためには、1か月以上摂取することがより望ましい。また、ホルモン剤等を含有しておらず、機能性食品等として市販されている成分を含有しているため、長期の摂取も可能であり、数か月以上摂取することも可能である。 The intake amount and the number of intakes of the oral composition of the present embodiment vary depending on the intake form, the age, weight, symptoms, etc. of the recipient. Usually, it is desirable to take 5,000 to 7,000 mg as an arginine-containing composition and 1,500 to 2,000 mg as a proanthocyanidin-containing composition per day for an adult. This amount is preferably taken once to several times a day, and most preferably taken twice a day. Since the oral composition of this embodiment can express the improvement effect of a sexual function faster, as an intake period may be shorter than before, for example, 2 weeks or more are desirable. Moreover, in order to maintain the outstanding improvement effect more, it is more desirable to ingest for one month or more. In addition, since it contains no hormones or the like and contains components that are commercially available as functional foods, it can be ingested for a long period of time, and can be ingested for several months or more.
以下、実施例及び試験例挙げて本発明をさらに具体的に説明するが、これらは単なる例示であって、本発明を限定するものではない。 EXAMPLES Hereinafter, although an Example and a test example are given and this invention is demonstrated further more concretely, these are only illustrations and do not limit this invention.
(実施例1)
1.アルギニン含有組成物の調製
下記表1に示す原料をそれぞれ計量し、既存の混合装置を用いて混合した後、既存の造粒装置を用いてアルギニン含有組成物の顆粒剤を調製した。次いで、この顆粒剤を既存の充填包装装置を用いて、下記表1に示すような分量なるように分包した。本実施例では、スティック状に分包(包材を棒状にして内容物を充填する包装形態)して、いわゆるスティック顆粒剤とすることで、製品のスリム化や簡易化等を図り、ユーザが手軽に携帯や摂取がし易いようにした。スティック顆粒剤1本分の各組成の分量、並びに1日の摂取の目安としてのスティック2本分の各組成の分量を、下記表1に示す。
Example 1
1. Preparation of Arginine-Containing Composition After the raw materials shown in Table 1 below were weighed and mixed using an existing mixing device, granules of the arginine-containing composition were prepared using an existing granulating device. Subsequently, this granule was packaged using an existing filling and packaging apparatus so as to have an amount as shown in Table 1 below. In this embodiment, the stick is packaged (packaging form in which the packaging material is filled in the form of a stick) and is used as a so-called stick granule, so that the product can be slimmed and simplified, etc. Easy to carry and ingest. The amount of each composition for one stick granule and the amount of each composition for two sticks as a guide for daily intake are shown in Table 1 below.
2.プロアントシアニジン含有組成物の調製
下記表2に示す原料をそれぞれ計量し、既存の混合装置を用いて混合してプロアントシアニジン含有組成物を調製した。次いで、既存のカプセル充填装置を用いて、下記表2に示す分量のプロアントシアニジン含有組成物をハードカプセル(2号)に充填し、ハードカプセル剤を得た。ハードカプセル剤1粒分の各組成物の分量、並びに1日の摂取の目安としての6粒分の各組成物の分量を、下記表2に示す。
2. Preparation of proanthocyanidin-containing composition The raw materials shown in Table 2 below were weighed and mixed using an existing mixing device to prepare a proanthocyanidin-containing composition. Next, the hard capsule (No. 2) was filled with the proanthocyanidin-containing composition of the amount shown in Table 2 below using an existing capsule filling device to obtain a hard capsule. Table 2 below shows the amount of each composition for one hard capsule and the amount of each composition for six capsules as a guide for daily intake.
上記アルギニン含有組成物のスティック顆粒剤とプロアントシアニジン含有組成物のハードカプセル剤とで実施例1の経口組成物とした。また、顆粒剤の1日の摂取分を1本ではなく2本に分け、ハードカプセル剤の1日の摂取分を1粒ではなく6粒に分けることで、症状や改善目的、摂取時間等に応じて、摂取量を適宜調整することが可能である。 The oral composition of Example 1 was made up of the above-mentioned arginine-containing composition stick granule and the proanthocyanidin-containing composition hard capsule. Also, by dividing the daily intake of granules into two instead of one, and dividing the daily intake of hard capsules into six instead of one, according to symptoms, improvement purpose, intake time, etc. Thus, it is possible to adjust the intake amount as appropriate.
3.テストステロンの血中濃度変化試験
実施例1の経口組成物を、10人の男性被検者に投与して、テストステロンの血中濃度の変化を観察した。1日の摂取量は、表1、表2に示すとおりであり、アルギニン含有組成物(スティック顆粒)1本、プロアントシアニジン含有組成物(ハードカプセル剤)3粒を、1日2回摂取した。
3. Testosterone blood concentration change test The oral composition of Example 1 was administered to 10 male subjects, and changes in blood testosterone concentration were observed. The daily intake was as shown in Tables 1 and 2, and one arginine-containing composition (stick granule) and three proanthocyanidin-containing compositions (hard capsules) were taken twice a day.
血液検査による経口組成物の摂取前のテストステロン血中濃度と、経口組成物を1カ月継続して摂取した後のテストステロン血中濃度の測定結果を下記表3に示す。 Table 3 below shows the measurement results of the blood testosterone blood concentration before ingestion of the oral composition by blood test and the blood testosterone blood concentration after ingestion of the oral composition continuously for one month.
上記表3に示すように、実施例1の経口組成物を摂取することで、1カ月後には10人中7人のテストステロン血中濃度が上昇した。テストステロンの上昇によって、被検者の性的機能の向上や、勃起不全等の性的機能の改善が見られた。この結果より、実施例1の経口組成物は、男性の性的機能等の優れた改善効果を、より速く、より効果的に発揮することが可能であることが判明した。なお、血液検査によれば、テストステロンの血中濃度は上昇したが、肝機能や腎機能等の検査結果には、殆ど変化がなく、実施例1の経口組成物の摂取によって肝機能や腎機能等が影響されないことも判明した。 As shown in Table 3 above, ingestion of the oral composition of Example 1 increased the testosterone blood concentration in 7 out of 10 patients after 1 month. The increase in testosterone showed an improvement in the sexual function of the subject and an improvement in sexual functions such as erectile dysfunction. From this result, it was found that the oral composition of Example 1 was able to exhibit an excellent improvement effect such as male sexual function faster and more effectively. In addition, according to the blood test, the blood testosterone concentration increased, but the test results such as liver function and kidney function were almost unchanged, and the liver function and kidney function were ingested by ingestion of the oral composition of Example 1. It has also been found that etc. are not affected.
以上、本発明の経口組成物を実施の形態及び実施例に基づき説明してきたが、具体的な構成については、この実施の形態及び実施例に限られるものではなく、特許請求の範囲の各請求項に係る発明の要旨を逸脱しない限り、設計の変更や追加等は許容される。 As mentioned above, although the oral composition of this invention has been demonstrated based on embodiment and an Example, as for a concrete structure, it is not restricted to this embodiment and an Example, Each claim of a claim Design changes and additions are permitted without departing from the spirit of the invention according to the paragraph.
Claims (5)
プロアントシアニジン、及び亜鉛を含有するプロアントシアニジン含有組成物と、を有する経口組成物。 An arginine-containing composition comprising arginine, sodium aspartate, and citrulline;
An oral composition comprising proanthocyanidins and a proanthocyanidin-containing composition containing zinc.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016148618A JP2018016588A (en) | 2016-07-28 | 2016-07-28 | Oral composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016148618A JP2018016588A (en) | 2016-07-28 | 2016-07-28 | Oral composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2018016588A true JP2018016588A (en) | 2018-02-01 |
Family
ID=61075102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016148618A Pending JP2018016588A (en) | 2016-07-28 | 2016-07-28 | Oral composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2018016588A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108935685A (en) * | 2018-08-15 | 2018-12-07 | 新疆天健禾牧生物技术有限公司 | A kind of dairy products promoting 3male hormone secretion |
| WO2021201169A1 (en) * | 2020-03-31 | 2021-10-07 | 株式会社ダンテ | Composition for oral ingestion for improving sperm finding in male infertility |
-
2016
- 2016-07-28 JP JP2016148618A patent/JP2018016588A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108935685A (en) * | 2018-08-15 | 2018-12-07 | 新疆天健禾牧生物技术有限公司 | A kind of dairy products promoting 3male hormone secretion |
| WO2021201169A1 (en) * | 2020-03-31 | 2021-10-07 | 株式会社ダンテ | Composition for oral ingestion for improving sperm finding in male infertility |
| JP2021159007A (en) * | 2020-03-31 | 2021-10-11 | 医療法人社団杉一会 | Composition for oral ingestion to improve sperm findings in male infertility |
| JP7149541B2 (en) | 2020-03-31 | 2022-10-07 | 医療法人社団杉一会 | Oral composition for improving sperm findings in male infertility |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6544563B2 (en) | Method and composition for improving sexual fitness | |
| ES2426481T3 (en) | Nutritional powders comprising spray dried HMB | |
| US20050276839A1 (en) | Appetite satiation and hydration beverage | |
| JP5507802B2 (en) | Muscle aging inhibitor | |
| US10945979B1 (en) | Amino acid compositions to promote endothelial health | |
| CN101810223A (en) | Functional milky tea powder and preparation method thereof | |
| ES2236589T3 (en) | Chewable tablet containing Lysine. | |
| CN105495582A (en) | Anti-fatigue and restorative health-care food amino acid composition | |
| AU2002310212B2 (en) | Method and composition for enhancing sexual desire | |
| AU2002310212A1 (en) | Method and composition for enhancing sexual desire | |
| CN101296693B (en) | Endurance improver | |
| JP2018016588A (en) | Oral composition | |
| MXPA06001706A (en) | Multivitamin syrup for children or young adults. | |
| CN103478718B (en) | Functional food for improving glutathione concentration in human body and preparation method thereof | |
| US7371415B1 (en) | Method and composition for improving sexual fitness | |
| JP6554292B2 (en) | Method for exerting endurance improving action or anti-fatigue action | |
| WO2023194470A1 (en) | Improving semen quality | |
| JP6646369B2 (en) | Anti-fatigue agent | |
| US20220387482A1 (en) | Performance enhancement delivery system | |
| TWI692313B (en) | Use of sports supplement composition | |
| US11617714B2 (en) | Sublingual therapeutic solutions and methods | |
| JP2025081772A (en) | Bloodstream ameliorating composition | |
| JP2024002801A (en) | Oral composition | |
| JP2022121730A (en) | anti-fatigue | |
| JP2020150826A (en) | Oral composition |